Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term lymphocytes. Found 22 abstracts

no pagination
Chu CS, Boyer J, Schullery DS, Gimotty PA, Gamerman V, Bender J, Levine BL, Coukos G, Rubin SC, Morgan MA, Vonderheide RH, June CH. Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer Immunology Immunotherapy. 2012 May;61(5):629-41.
Fang M, Siciliano NA, Hersperger AR, Roscoe F, Hu A, Ma XY, Shamsedeen AR, Eisenlohr LC, Sigal LJ. Perforin-dependent CD4(+) T-cell cytotoxicity contributes to control a murine poxvirus infection. Proceedings of the National Academy of Sciences of the United States of America. 2012 Jun;109(25):9983-8.   PMCID: PMC3382508
De Keersmaecker K, Real PJ, Della Gatta G, Palomero T, Sulis ML, Tosello V, Van Vlierberghe P, Barnes K, Castillo M, Sole X, Hadler M, Lenz J, Aplan PD, Kelliher M, Kee BL, Pandolfi PP, Kappes D, Gounari F, Petrie H, Van der Meulen J, Speleman F, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Soulier J, Avran D, Cave H, Dastugue N, Raimondi S, Meijerink JP, Cordon-Cardo C, Califano A, Ferrando AA. The TLX1 oncogene drives aneuploidy in T cell transformation. Nature medicine. 2010 Nov;16(11):1321-7.   PMCID: PMC2974790
Tsai DE, Aqui NA, Tomaszewski JE, Olthoff KM, Ahya VN, Kotloff RM, Bloom RD, Brozena SC, Hodinka RL, Stadtmauer EA, Schuster SJ, Nasta SD, Porter DL, Luger SM, Klumpp TR. Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder. Clinical transplantation. 2005 Oct;19(5):644-52.
Chmielewski M, Hombach A, Heuser C, Adams GP, Abken H. T cell activation by antibody-like immunoreceptors: Increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity. Journal of Immunology. 2004 Dec 15;173(12):7647-53.
Wu H, Barusevicius A, Lessin SR. Granuloma annulare with a mycosis fungoides-like distribution and palisaded granulomas of CD68-positive histiocytes. Journal of the American Academy of Dermatology. 2004 Jul;51(1):39-44.
Burdin N, Brossay L, Degano M, Iijima H, Gui M, Wilson IA, Kronenberg M. Structural requirements for antigen presentation by mouse CD1. Proceedings of the National Academy of Sciences of the United States of America. 2000 Aug 29;97(18):10156-61.
Sigal LJ, Rock KL. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)- dependent and -independent pathways of antigen presentation. Journal of Experimental Medicine. 2000 Oct 16;192(8):1143-50.
Kruk PA, Godwin AK, Hamilton TC, Auersperg N. Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer. Gynecologic Oncology. 1999 May;73(2):229-36.
Segal DM, Weiner GJ, Weiner LM. Bispecific antibodies in cancer therapy. Current Opinion in Immunology. 1999 Oct;11(5):558-62.
Clark JI, Alpaugh RK, vonMehren M, Schultz J, Gralow JR, Cheever MA, Ring DB, Weiner LM. Induction of multiple anti-c-erB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment. Cancer Immunology Immunotherapy. 1997 Jul;44(5):265-72.
Wasserman R, Li YS, Hardy RR. Down-regulation of terminal deoxynucleotidyl transferase by Ig heavy chain in B lineage cells. Journal of Immunology. 1997 Feb;158(3):1133-8.
Amoroso AR, Clark JI, Litwin S, HsiehMa S, Shi T, Alpaugh RK, Adams GP, Wolf EJ, Ring DB, Weiner LM. Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor. Cancer Research. 1996 Jan;56(1):113-20.
GercelTaylor C, Hoffman JP, Taylor DD, Owens KJ, Eisenberg BL. Interleukin-2 activation of cytotoxic cells in postmastectomy seroma. Journal of Surgical Research. 1996 Feb 15;61(1):89-96.
Gwin JL, GercelTaylor C, Taylor DD, Eisenberg B. Role of LFA-3, ICAM-1, and MHC class I on the of human tumor cells to LAK cells. Journal of Surgical Research. 1996 Jan;60(1):129-36.
Rose GS, Tocco LM, Granger GA, DiSaia PJ, Hamilton TC, Santin AD, Hiserodt JC. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. American journal of obstetrics and gynecology. 1996 Sep;175(3):593-9.
Weiner LM, Alpaugh RK, Amoroso AR, Adams GP, Ring DB, Barth MW. Human neutrophil interactions of a bispecific monoclonal antibody targeting tumor and human Fc gamma RIII. Cancer Immunology Immunotherapy. 1996 Mar;42(3):141-50.
Weiner LM, Clark JI, Davey M, Li WS, Depalazzo IG, Ring DB, Alpaugh RK. Phase-I Trial of 2b1, a Bispecific Monoclonal-Antibody Targeting C-Erbb-2 and Fc-Gamma-Riii. Cancer Research. 1995 Oct 15;55(20):4586-93.
Hayakawa K, Tarlinton D, Hardy RR. Absence of Mhc Class-Ii Expression Distinguishes Fetal from Adult B-Lymphopoiesis in Mice. Journal of Immunology. 1994 May 15;152(10):4801-7.
Yeung RS. Recurrent Cutaneous Melanoma - a Surgical Perspective. Seminars in Oncology. 1993 Oct;20(5):400-18.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term lymphocytes

lymphocytes expression cancer carcinoma hybrid hybridomas antigens invitro mice therapy t-cells survival bone-marrow cytotoxicity tumor-cells cell activation breast-cancer molecules recognition lysis induction receptor monoclonal-antibody gene tcr epstein-barr-virus particulate antigens activation phase-i trial irradiation cytokine release lymphomagenesis cells mutations her-2 flow cytometric analysis gene-expression bone-marrow transplantation li-fraumeni syndrome Dendritic cell Ovarian cancer-Vaccine-Clinical trial-Consolidation therapy vivo transfection mousepox rag-1- transgenic mice protection tumor necrosis factor responses isolated regional perfusion immunotherapy cytotoxic T lymphocytes CD4(+) T lymphocytes-viral immunology-viral pathogenesis immunoglobulin transgenes kinase peptide serum protein electrophoresis intraperitoneal treatment mononuclear-cells animal model cellular okt3 undetermined significance anti-target cell notch1 in-transit metastases susceptibility natural host human-melanoma cells t- ovarian cancer tumor-associated antigen immune-response alpha-galactosylceramide cytotoxic complex class-i ovarian-cancer mediated cytotoxicity activated killer-cells cell lymphoma dendritic cells adhesion T conservation therapy c-erbB-2 malignant-lymphoma recipients cd28 costimulation cd16 cancer-patients toxicity mouse bispecific antibody deficient mice phase-i dna-based immunization macrophages prognostic factors identification human neutrophil interactions secretion neoplasms major histocompatibility isolated limb perfusion patch nk t-cells mhc class-i complex dermatitis mediated resistance binding interferon-gamma antibodies immunogenicity neu bcl11b supralethal metastatic malignant-melanoma central nervous-system monoclonal gammopathy targeting regulatory t-cells length ovarian neoplasm scid mice bispecific monoclonal glycolipids crystal-structure NuTu-19 immunization selection rna component recombinant interleukin-2 immortal cells organ transplantation f344 rats v(d)j recombination long-term immunosuppression immunoglobulin t-cell activation single-chain fv disease Fischer 344 cellular cytotoxicity antigen expression human fibroblasts natural-killer cells ovarian-carcinoma signaling receptor escherichia-coli ifn-gamma recombinant immunoreceptors post-transplant lymphoproliferative disorder
Last updated on Wednesday, August 12, 2020